Novel delivery methods for treatment of viral hepatitis: an update.
Virovic L, Wu CH, Konishi M, Wu GY.
Expert Opin Drug Deliv. 2005 Jul;2(4):707-17. doi: 10.1517/17425247.2.4.707.
PMID:16296795
Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance.
Meng CY, Sun S, Liang Y, Xu H, Zhang C, Zhang M, Wang FS, Fu YX, Peng H.
Gut. 2023 Aug;72(8):1544-1554. doi: 10.1136/gutjnl-2022-327059. Epub 2022 Oct 31.
PMID:36316098
Hepatocellular carcinoma associated with chronic viral hepatitis. Aetiology, diagnosis and treatment.
Dusheiko GM.
Br Med Bull. 1990 Apr;46(2):492-511. doi: 10.1093/oxfordjournals.bmb.a072412.
PMID:2165844
Lipid nanoparticle-mediated delivery of IL-21-encoding mRNA induces viral clearance in mouse models of hepatitis B virus persistence.
Shen Z, Zhang S, Jiang Q, Liu N, Li F, Gao Z, Pan S, Hao W, Deng Q, Liu J, Zhang J, Xie Y.
J Med Virol. 2023 Sep;95(9):e29062. doi: 10.1002/jmv.29062.
PMID:37665238
The effect of intrahepatic cholestasis in pregnancy combined with different stages of hepatitis B virus infection on pregnancy outcomes: a retrospective study.